GlassScriptPhysician profile
Howard Goldberg
NPI 1659303808
$1,878.09
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $249 · 2021: $367 · 2022: $986.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $303.07 | 2019-2022 | |
| Rochester Medical Corporation | $225.09 | 2022 | |
| Pfizer INC. | $173.38 | 2019-2022 | |
| Procept Biorobotics Corporation | $172.58 | 2022 | |
| Endo Pharmaceuticals INC. | $137.90 | 2019-2022 | |
| Coloplast Corp | $119.14 | 2019-2022 | |
| Myovant Sciences INC. | $104.88 | 2021-2022 | |
| Blue Earth Diagnostics | $87.62 | 2021-2022 | |
| Antares Pharma, INC. | $70.02 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.67 | 2022 | |
| Myriad Genetic Laboratories, INC. | $52.52 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $49.28 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $44.70 | 2021 | |
| Boston Scientific Corporation | $35.07 | 2020-2022 | |
| Neotract INC. | $30.69 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $25.09 | 2022 | |
| Abbott Laboratories | $19.98 | 2020 | |
| Teleflex LLC | $19.51 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.99 | 2019 | |
| Ethicon US, LLC | $17.49 | 2022 | |
| Urovant Sciences INC | $16.93 | 2022 | |
| Travere Therapeutics, INC. | $16.44 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $16.09 | 2022 | |
| Abbvie INC. | $15.49 | 2019 | |
| Olympus America INC. | $15.06 | 2021 | |
| Axonics, INC. | $13.28 | 2021 | |
| Laborie Medical Technologies Corp. | $12.89 | 2020 | |
| Acerus Pharmaceuticals Corporation | $11.24 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.